Evidence map›Paper›PMID 36075013›Full record

ArticleJCO oncology practice2022

Differences in Pretreatment Frailty Across Gastrointestinal Cancers in Older Adults: Results From the Cancer and Aging Resilience Evaluation Registry.

Sankalp Arora, Mackenzie E Fowler, Christian Harmon, Mustafa Al-Obaidi, Darryl Outlaw, Robert Hollis, Olumide Gbolahan, Moh'd Khushman, Smith Giri, Grant R Williams

Open access · greenAbstract read
In one paragraph

Article in JCO oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sankalp AroraDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-8162-4119
Mackenzie E FowlerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0003-2952-3705
Christian HarmonInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Mustafa Al-ObaidiInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL.
Darryl OutlawDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0001-9618-6935
Robert HollisInstitute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-6761-9890
Olumide GbolahanDepartment of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA.
Moh'd KhushmanDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Smith GiriDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0002-1827-5032
Grant R WilliamsDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL.ORCID 0000-0003-4294-5232
University of Alabama at Birmingham · USEmory University · US

Funding

UAB Health Services Research (HSR) Training ProgramT32HS013852 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVITAN, EMILY B, MUGAVERO, MICHAEL J · 2003 to 2024
$8.0M
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M StudyK08CA234225 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WILLIAMS, GRANT R · 2018 to 2022
$1.0M
AHRQ HHS T32 HS013852NCI NIH HHS K08 CA234225
6 · The paper itself

Abstract

purposeFrailty predicts poor outcomes in older adults with cancer, but how it differs between different cancer types is unknown. We examined differences in pretreatment frailty between colorectal (CRC), pancreatic, and hepatobiliary cancers.

methodsWe included older adults age 60 years or older with the above cancer types enrolled in the Cancer and Aging Resilience Evaluation registry. Frailty was defined using a 44-item Cancer and Aging Resilience Evaluation frailty index constructed on the basis of the principles of deficit accumulation (including several geriatric assessment impairments encompassing malnutrition, functional status, comorbidities, anxiety, depression, cognitive complaints, health-related quality of life, falls, ability to walk one block, interference in social activities, and polypharmacy). Multivariable logistic regression models were used to examine the adjusted odds ratio (aOR) of frailty between cancer types.

resultsA total of 505 patients were included (mean age 70 years, 59% male): 211 (41.8%) CRC, 178 (35.2%)pancreatic cancer, and 116 (23.0%) hepatobiliary cancer. Patients with pancreatic cancer had the highest prevalence of frailty (23.3% CRC, 40.6% pancreatic, 34.3% hepatobiliary;

conclusionOlder adults with pancreatic and hepatobiliary cancers are at high-risk of pretreatment frailty. Early interventions to improve nutritional and functional status and optimization of comorbidities may help improve outcomes.

Indexed as

FrailtyGastrointestinal NeoplasmsMalnutritionPancreatic NeoplasmsActivities of Daily LivingAgedAgingFemaleHumansMaleMiddle AgedQuality of LifeRegistries

Identifiers

PMID36075013
PMCPMC9653204
OpenAlexW4295084522

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.